miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor.
miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor. Biochem Biophys Res Commun. 2011 Mar 25; 406(4):518-23.